Humana (HUM) Notes Payables (2009 - 2026)

Humana (HUM) has 18 years of Notes Payables data on file, last reported at $297.0 million in Q1 2026.

• On a quarterly basis, Notes Payables fell 19.73% year-over-year to $297.0 million in Q1 2026; TTM through Mar 2026 was $297.0 million, a 19.73% decrease from a year earlier, with the FY2025 full-year figure at $306.0 million, down 24.07% from the prior year.
• Notes Payables for Q1 2026 stood at $297.0 million, down from $306.0 million in the prior quarter.
• Over the last five years, Notes Payables for HUM reached as high as $457.0 million in Q2 2023 and fell as low as $237.0 million in Q3 2022.
• Historically, Notes Payables has averaged $337.1 million across 5 years, with a median of $333.0 million in 2024.
• Across the five-year window, Notes Payables surged 65.68% in 2022 and declined 24.07% in 2025, its largest moves.
• Year by year, Notes Payables stood at $298.0 million in 2022, then increased by 18.46% to $353.0 million in 2023, then increased by 14.16% to $403.0 million in 2024, then slipped by 24.07% to $306.0 million in 2025, then declined by 2.94% to $297.0 million in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $297.0 million in Q1 2026, $306.0 million in Q4 2025, and $308.0 million in Q3 2025.